Immune Stress-induced Tumor Mutation Burden and Neoantigen Expression in 4T1 Mammary Cancer Cells: A Potential Mechanism for Long-term Survival in Patients Treated With Immune Checkpoint Inhibitors.
Saved in:
| Title: | Immune Stress-induced Tumor Mutation Burden and Neoantigen Expression in 4T1 Mammary Cancer Cells: A Potential Mechanism for Long-term Survival in Patients Treated With Immune Checkpoint Inhibitors. |
|---|---|
| Authors: | Ishiguro T; Department of Medicine, Division of Medical Oncology, School of Medicine, Showa University, Tokyo, Japan., Takeda K; Laboratory of Cell Biology, Biomedical Research Core Facilities, Graduate School of Medicine, Juntendo University, Tokyo, Japan., Takayanagi D; Department of Medicine, Division of Medical Oncology, School of Medicine, Showa University, Tokyo, Japan., Mura E; Department of Medicine, Division of Medical Oncology, School of Medicine, Showa University, Tokyo, Japan., Suzuki R; Department of Medicine, Division of Medical Oncology, School of Medicine, Showa University, Tokyo, Japan., Tsurui T; Department of Medicine, Division of Medical Oncology, School of Medicine, Showa University, Tokyo, Japan., Iriguchi N; Department of Medicine, Division of Medical Oncology, School of Medicine, Showa University, Tokyo, Japan., Hirasawa Y; Department of Medicine, Division of Medical Oncology, School of Medicine, Showa University, Tokyo, Japan., Ohkuma R; Department of Medicine, Division of Medical Oncology, School of Medicine, Showa University, Tokyo, Japan., Shimokawa M; Department of Medicine, Division of Medical Oncology, School of Medicine, Showa University, Tokyo, Japan., Ariizumi H; Department of Medicine, Division of Medical Oncology, School of Medicine, Showa University, Tokyo, Japan., Kubota Y; Department of Medicine, Division of Medical Oncology, School of Medicine, Showa University, Tokyo, Japan., Horiike A; Department of Medicine, Division of Medical Oncology, School of Medicine, Showa University, Tokyo, Japan., Izumizaki M; Department of Physiology, School of Medicine, Showa University, Tokyo, Japan., Wada S; Department of Medicine, Division of Medical Oncology, School of Medicine, Showa University, Tokyo, Japan.; Department of Clinical Diagnostic Oncology, Clinical Research Institute for Clinical Pharmacology & Therapeutics, Showa University, Tokyo, Japan., Yoshimura K; Department of Medicine, Division of Medical Oncology, School of Medicine, Showa University, Tokyo, Japan.; Department of Clinical Immuno-Oncology, Clinical Research Institute of Clinical Pharmacology and Therapeutics, Showa University, Tokyo, Japan., Hoffman RM; AntiCancer Inc., San Diego, CA, U.S.A.; Department of Surgery, University of California, San Diego, CA, U.S.A., Tsunoda T; Department of Medicine, Division of Medical Oncology, School of Medicine, Showa University, Tokyo, Japan; ttsunoda@med.showa-u.ac.jp. |
| Source: | Cancer genomics & proteomics [Cancer Genomics Proteomics] 2025 Jan-Feb; Vol. 22 (1), pp. 1-12. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: International Institute of Anticancer Research Country of Publication: Greece NLM ID: 101188791 Publication Model: Print Cited Medium: Internet ISSN: 1790-6245 (Electronic) Linking ISSN: 11096535 NLM ISO Abbreviation: Cancer Genomics Proteomics Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39730175 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Immune Stress-induced Tumor Mutation Burden and Neoantigen Expression in 4T1 Mammary Cancer Cells: A Potential Mechanism for Long-term Survival in Patients Treated With Immune Checkpoint Inhibitors. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Ishiguro+T%22">Ishiguro T</searchLink>; Department of Medicine, Division of Medical Oncology, School of Medicine, Showa University, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Takeda+K%22">Takeda K</searchLink>; Laboratory of Cell Biology, Biomedical Research Core Facilities, Graduate School of Medicine, Juntendo University, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Takayanagi+D%22">Takayanagi D</searchLink>; Department of Medicine, Division of Medical Oncology, School of Medicine, Showa University, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Mura+E%22">Mura E</searchLink>; Department of Medicine, Division of Medical Oncology, School of Medicine, Showa University, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Suzuki+R%22">Suzuki R</searchLink>; Department of Medicine, Division of Medical Oncology, School of Medicine, Showa University, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Tsurui+T%22">Tsurui T</searchLink>; Department of Medicine, Division of Medical Oncology, School of Medicine, Showa University, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Iriguchi+N%22">Iriguchi N</searchLink>; Department of Medicine, Division of Medical Oncology, School of Medicine, Showa University, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Hirasawa+Y%22">Hirasawa Y</searchLink>; Department of Medicine, Division of Medical Oncology, School of Medicine, Showa University, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Ohkuma+R%22">Ohkuma R</searchLink>; Department of Medicine, Division of Medical Oncology, School of Medicine, Showa University, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Shimokawa+M%22">Shimokawa M</searchLink>; Department of Medicine, Division of Medical Oncology, School of Medicine, Showa University, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Ariizumi+H%22">Ariizumi H</searchLink>; Department of Medicine, Division of Medical Oncology, School of Medicine, Showa University, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Kubota+Y%22">Kubota Y</searchLink>; Department of Medicine, Division of Medical Oncology, School of Medicine, Showa University, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Horiike+A%22">Horiike A</searchLink>; Department of Medicine, Division of Medical Oncology, School of Medicine, Showa University, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Izumizaki+M%22">Izumizaki M</searchLink>; Department of Physiology, School of Medicine, Showa University, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Wada+S%22">Wada S</searchLink>; Department of Medicine, Division of Medical Oncology, School of Medicine, Showa University, Tokyo, Japan.; Department of Clinical Diagnostic Oncology, Clinical Research Institute for Clinical Pharmacology & Therapeutics, Showa University, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Yoshimura+K%22">Yoshimura K</searchLink>; Department of Medicine, Division of Medical Oncology, School of Medicine, Showa University, Tokyo, Japan.; Department of Clinical Immuno-Oncology, Clinical Research Institute of Clinical Pharmacology and Therapeutics, Showa University, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Hoffman+RM%22">Hoffman RM</searchLink>; AntiCancer Inc., San Diego, CA, U.S.A.; Department of Surgery, University of California, San Diego, CA, U.S.A.<br /><searchLink fieldCode="AU" term="%22Tsunoda+T%22">Tsunoda T</searchLink>; Department of Medicine, Division of Medical Oncology, School of Medicine, Showa University, Tokyo, Japan; ttsunoda@med.showa-u.ac.jp. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101188791%22">Cancer genomics & proteomics</searchLink> [Cancer Genomics Proteomics] 2025 Jan-Feb; Vol. 22 (1), pp. 1-12. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22International+Institute+of+Anticancer+Research%22">International Institute of Anticancer Research </searchLink><i>Country of Publication: </i>Greece <i>NLM ID: </i>101188791 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1790-6245 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2211096535%22">11096535 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Genomics Proteomics <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39730175 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.21873/cgp.20481 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1 Titles: – TitleFull: Immune Stress-induced Tumor Mutation Burden and Neoantigen Expression in 4T1 Mammary Cancer Cells: A Potential Mechanism for Long-term Survival in Patients Treated With Immune Checkpoint Inhibitors. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Ishiguro T – PersonEntity: Name: NameFull: Takeda K – PersonEntity: Name: NameFull: Takayanagi D – PersonEntity: Name: NameFull: Mura E – PersonEntity: Name: NameFull: Suzuki R – PersonEntity: Name: NameFull: Tsurui T – PersonEntity: Name: NameFull: Iriguchi N – PersonEntity: Name: NameFull: Hirasawa Y – PersonEntity: Name: NameFull: Ohkuma R – PersonEntity: Name: NameFull: Shimokawa M – PersonEntity: Name: NameFull: Ariizumi H – PersonEntity: Name: NameFull: Kubota Y – PersonEntity: Name: NameFull: Horiike A – PersonEntity: Name: NameFull: Izumizaki M – PersonEntity: Name: NameFull: Wada S – PersonEntity: Name: NameFull: Yoshimura K – PersonEntity: Name: NameFull: Hoffman RM – PersonEntity: Name: NameFull: Tsunoda T IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 01 Text: 2025 Jan-Feb Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1790-6245 Numbering: – Type: volume Value: 22 – Type: issue Value: 1 Titles: – TitleFull: Cancer genomics & proteomics Type: main |
| ResultId | 1 |
